Search results
Author(s):
Roland R Tilz
Added:
1 month ago
EHRA Congress 2026 – Prof Roland Tilz (University Hospital Schleswig-Holstein, Lübeck, DE) presents the findings from the TiFFANY-AF study, a retrospective observational analysis evaluating real-world mortality outcomes associated with pulsed field ablation compared with thermal ablation techniques — radiofrequency and cryoballoon — for atrial fibrillation.Drawing on a decade of data from the US…
View more
AF and Mortality in MI Patients
Author(s):
Ferdinand Bauke
,
Christa Meisinger
,
Philip Raake
,
et al
Added:
1 year ago
Original Research
Added:
7 months ago
Source:
Radcliffe Cardiology
AUTHOR: Jordan RanceRisk stratification for primary prevention implantable cardioverter-defibrillator (ICD) placement in patients with cardiac sarcoidosis remains a clinical challenge, partly due to inconsistencies in diagnostic criteria and the variable course of the disease. A new study published in the European Heart Journal suggests that cardiovascular magnetic resonance (CMR) phenotyping has…
View more
Author(s):
Francesco Santoro
Added:
1 month ago
EHRA 2026 — Dr Francesco Santoro joins us to discuss findings from his meta-analysis of randomised controlled trials comparing catheter ablation with anti-arrhythmic drug therapy in patients with ventricular tachycardia and ischaemic heart disease.This meta-analysis pooled data from four RCTs enrolling 947 patients with ischaemic heart disease and ICD implantation, randomised to either catheter…
View more
Mitral Annular Disjunction
Author(s):
Avi Sabbag
,
Konstantinos C Siontis
Added:
1 month ago
Editorial
Medical Therapy of Heart Failure and AF
Author(s):
Gregory Burkman
,
Gerald V Naccarelli
Added:
1 week ago
Review Article
Author(s):
Kenneth Bilchick
Added:
2 weeks ago
HRS Congress 2026 — Dr Kenneth Bilchick (UVA Heart & Vascular Center, Charlottesville, VA, US) joins us to discuss findings from a study examining whether the protective effect of glucagon-like peptide-1 (GLP-1) receptor agonists on atrial fibrillation risk operates independently of weight loss and survival.Interview Questions:What is the current understanding of how GLP-1 receptor agonists may…
View more
Author(s):
Demosthenes G Katritsis
,
Robert H Anderson
Added:
2 months ago
Real-world Outcomes of AVNA: 10-year Results
Author(s):
Anette Caroline Kõre
,
Martin Serg
,
Tuljo Ööbik
,
et al
Added:
3 months ago
Original Research
Author(s):
Maria Niespialowska-Steuden
,
John Silberbauer
,
Jaffar Al-Sheikhli
,
et al
Added:
1 week ago